Ilevro, Nevanac (nepafenac) is a small molecule pharmaceutical. Nepafenac was first approved as Ilevro on 2005-08-19. It is used to treat eye pain in the USA. It has been approved in Europe to treat ophthalmologic surgical procedures and postoperative pain. Nevanac's patents are valid until 2032-03-31 (FDA).
|Indication||eye pain, ophthalmologic surgical procedures, postoperative pain|
|Drug Class||Anti-inflammatory agents (acetic acid derivatives)|